Literature DB >> 19921542

Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Sigrid Vorobjov1, Anneli Uusküla, Katri Abel-Ollo, Ave Talu, Don Des Jarlais.   

Abstract

Despite the high number of injecting drug users (IDUs) in Estonia, little is known about involving pharmacies into human immunodeficiency virus (HIV) prevention activities and potential barriers. Similarly, in other Eastern European countries, there is a need for additional sources for clean syringes besides syringe exchange programmes (SEPs), but data on current practices relating to pharmacists' role in harm reduction strategies is scant. Involving pharmacies is especially important for several reasons: they have extended hours of operation and convenient locations compared to SEPs, may provide access for IDUs who have avoided SEPs, and are a trusted health resource in the community. We conducted a series of focus groups with pharmacists and IDUs in Tallinn, Estonia, to explore their attitudes toward the role of pharmacists in HIV prevention activities for IDUs. Many, but not all, pharmacists reported a readiness to sell syringes to IDUs to help prevent HIV transmission. However, negative attitudes toward IDUs in general and syringe sales to them specifically were identified as important factors restricting such sales. The idea of free distribution of clean syringes or other injecting equipment and disposal of used syringes in pharmacies elicited strong resistance. IDUs stated that pharmacies were convenient for acquiring syringes due to their extended opening hours and local distribution. IDUs were positive toward pharmacies, although they were aware of stigma from pharmacists and other customers. They also emphasized the need for distilled water and other injection paraphernalia. In conclusion, there are no formal or legislative obstacles for providing HIV prevention services for IDUs at pharmacies. Addressing negative attitudes through educational courses and involving pharmacists willing to be public health educators in high drug use areas would improve access for HIV prevention services for IDUs.

Entities:  

Mesh:

Year:  2009        PMID: 19921542      PMCID: PMC2791822          DOI: 10.1007/s11524-009-9400-5

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  26 in total

1.  Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.

Authors:  Josiah D Rich; Erika G Martin; Grace E Macalino; Rowan V Paul; Susan McNamara; Lynn E Taylor
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

2.  Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?

Authors:  C Matheson; C M Bond; J Pitcairn
Journal:  Addiction       Date:  2002-11       Impact factor: 6.526

3.  High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.

Authors:  Lucy Platt; Natalia Bobrova; Tim Rhodes; Anneli Uusküla; John V Parry; Kristi Rüütel; Ave Talu; Katri Abel; Kristiina Rajaleid; Ali Judd
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

4.  Access to syringes in three Russian cities: implications for syringe distribution and coverage.

Authors:  Anya Sarang; Tim Rhodes; Lucy Platt
Journal:  Int J Drug Policy       Date:  2008-03-03

5.  Injection drug users report good access to pharmacy sale of syringes.

Authors:  Wendy Reich; Wilson M Compton; Joeseph C Horton; Linda B Cottler; Renee M Cunningham-Williams; Robert Booth; Merrill Singer; Carl Leukefeld; Joseph Fink; Tom J Stopka; Karen Fortuin Corsi; Michelle Staton Tindall
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

6.  Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002).

Authors:  Ruth Finkelstein; Rebecca Tiger; Robert Greenwald; Rajat Mukherjee
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

7.  Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales.

Authors:  J Sheridan; J Strang; N Barber; A Glanz
Journal:  BMJ       Date:  1996-08-03

8.  Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Authors:  Cari L Miller; Mark Tyndall; Patricia Spittal; Kathy Li; Anita Palepu; Martin T Schechter
Journal:  J Urban Health       Date:  2002-06       Impact factor: 3.671

Review 9.  Epidemiology of hepatitis C virus infection in Australia.

Authors:  Gregory J Dore; Matthew Law; Margaret MacDonald; John M Kaldor
Journal:  J Clin Virol       Date:  2003-02       Impact factor: 3.168

10.  High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.

Authors:  Anneli Uusküla; Louise Anne McNutt; Jack Dehovitz; Krista Fischer; Robert Heimer
Journal:  Int J STD AIDS       Date:  2007-01       Impact factor: 1.359

View more
  6 in total

1.  Pharmacists' strategies for promoting medication adherence among patients with HIV.

Authors:  Jennifer Kibicho; Jill Owczarzak
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Nov-Dec

2.  Pharmacists and harm reduction: A review of current practices and attitudes.

Authors:  Tyler Watson; Christine Hughes
Journal:  Can Pharm J (Ott)       Date:  2012-05

3.  An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

Authors:  David C Perlman; Ashly E Jordan; Anneli Uuskula; Duong Thi Huong; Carmen L Masson; Bruce R Schackman; Don C Des Jarlais
Journal:  Int J Drug Policy       Date:  2015-04-27

Review 4.  Public health in community pharmacy: a systematic review of pharmacist and consumer views.

Authors:  Claire E Eades; Jill S Ferguson; Ronan E O'Carroll
Journal:  BMC Public Health       Date:  2011-07-21       Impact factor: 3.295

5.  Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.

Authors:  Ekaterina V Fedorova; Roman V Skochilov; Robert Heimer; Patricia Case; Leo Beletsky; Lauretta E Grau; Andrey P Kozlov; Alla V Shaboltas
Journal:  BMC Public Health       Date:  2013-03-01       Impact factor: 3.295

6.  Qualitative assessment of patients' perspectives and needs from community pharmacists in substance use disorder management.

Authors:  Sarah Fatani; Daniel Bakke; Marcel D'Eon; Anas El-Aneed
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.